个性化纳米疫苗基于刺痛激活纳米载体,用于强大的癌症免疫治疗
Yongjuan Li1, Ya Dong1, Danyang Shen1
1Medical Research Center, The First Affiliated Hospital of Zhengzhou University, The Center of Infection and Immunity, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
ACS nano
|January 16, 2025
概括
这项研究引入了一种新型纳米疫苗,通过激活树突细胞 (DC) 和刺激T细胞反应来增强抗瘤免疫力. 这种双重作用的方法在抑制瘤生长和建立长期免疫记忆方面显著有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 瘤特异性T细胞对免疫至关重要,但它们的有效性受到抗原呈现和树突细胞 (DC) 反应的限制.
- 树突细胞 (DCs) 是启动适应性免疫的关键参与者,弥合了对瘤的先天和适应性反应.
研究的目的:
- 使用双免疫功能聚合物纳米平台 (DIPNP) 开发一种极简的纳米疫苗,以增强抗瘤免疫力.
- 研究纳米疫苗对DC激活和T细胞刺激的机制.
- 在临床前瘤模型中评估纳米疫苗的治疗疗效.
主要方法:
- 制造一个双免疫功能聚合物纳米平台 (DIPNP) 封装卵蛋白 (OVA).
- 在实验室中对STING激活,DC成熟和内质网膜应激的评估.
- 在体内评估瘤生长抑制,免疫记忆和B16-OVA和EG7-OVA模型中的生存率.
- 用抗编程死亡配体1 (aPD-L1) 抗体进行组合治疗.
- 使用瘤细胞膜开发个性化的纳米疫苗.
主要成果:
- 纳米载体通过特定的分子途径 (干扰素调节因子3酸化,托尔类受体4激活) 有效诱导STING激活和DC成熟.
- 在体内研究表明,在已建立的瘤模型中,显著抑制瘤生长和建立长期免疫记忆.
- 与aPD-L1抗体的联合治疗显著延长了小鼠的存活时间.
- 来自瘤细胞膜的个性化纳米疫苗表现出高的抗瘤活性.
结论:
- 开发的纳米疫苗通过调节树突细胞功能和促进T细胞反应,有效增强抗瘤免疫力.
- DIPNP纳米平台为构建具有个性化癌症治疗潜力的先进纳米疫苗提供了一种多功能战略.
- 这种理性设计方法为未来抗癌免疫治疗策略提供了有希望的基础.
相关概念视频
01:30Cancer Vaccines
333
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
333
01:27Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K